Arkolith/Insider Trading/KTRA/Form 4

Hoffman Robert E.

President and CEO, DirectorKintara Therapeutics, Inc. (KTRA) · full profile →Form 4 · filed Feb 17, 2022
Net Buying
Open-Market Buys
$26K
Open-Market Sells
$0
Net Open-Market Flow
$26K
Transactions
1
1 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Feb 15, 2022Buy(P)55K$0.47$26K55K

Transaction Codes

P
Open-market purchase

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0000905718-22-000393) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML